Spire Wealth Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-100
| Closed | -$7.31K | – | 2316 |
|
|
2024
Q1 | $7.31K | Hold |
100
| – | – | ﹤0.01% | 1813 |
|
|
2023
Q4 | $7.25K | Hold |
100
| – | – | ﹤0.01% | 1842 |
|
|
2023
Q3 | $5.99K | Hold |
100
| – | – | ﹤0.01% | 1892 |
|
|
2023
Q2 | $7.21K | Hold |
100
| – | – | ﹤0.01% | 1903 |
|
|
2023
Q1 | $7.36K | Buy |
+100
| New | +$7.36K | ﹤0.01% | 1945 |
|
|
2022
Q3 | – | Sell |
-16
| Closed | -$1K | – | 2423 |
|
|
2022
Q2 | $1K | Sell |
16
-144
| -90% | -$9K | ﹤0.01% | 2533 |
|
|
2022
Q1 | $11K | Hold |
160
| – | – | ﹤0.01% | 2000 |
|
|
2021
Q4 | $15K | Hold |
160
| – | – | ﹤0.01% | 2224 |
|
|
2021
Q3 | $14K | Hold |
160
| – | – | ﹤0.01% | 1989 |
|
|
2021
Q2 | $13K | Hold |
160
| – | – | ﹤0.01% | 2029 |
|
|
2021
Q1 | $15K | Buy |
+160
| New | +$15K | ﹤0.01% | 2266 |
|